Composite drug-loaded gel and preparation method thereof
A gel and drug-carrying technology, which is applied in pharmaceutical formulations, medical preparations with non-active ingredients, and medical preparations containing active ingredients, etc. performance, mitigating burst phenomena, promoting the effect of the formation of
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
preparation example Construction
[0026] The embodiment of the present invention provides a preparation method of a composite drug-loaded gel, comprising the following steps:
[0027] S1, adding pyrrole and dopamine hydrochloride into water and mixing evenly, then adding ammonium persulfate, stirring and reacting, centrifuging and washing to obtain a polypyrrole-polydopamine nanocomposite material;
[0028] S2. The nanocomposite material is sequentially placed in a 1mol / L hydrochloric acid solution containing drug molecules and a graphene oxide aqueous solution, and centrifugally adsorbed to obtain a graphene oxide-polypyrrole-polydopamine nanocomposite drug-loaded material;
[0029] S3. After mixing the nano-composite drug-loaded material with the water-soluble polymer solution, add calcium chloride solution, stir and let stand to obtain a composite drug-loaded gel.
[0030] Specifically, in step S1, the mass ratio of pyrrole, dopamine hydrochloride and ammonium persulfate is 1:(1-2):(1-3), the temperature of...
Embodiment 1
[0043] This embodiment provides a method for preparing a composite drug-loaded gel, which specifically includes the following steps:
[0044] 1) Add 1 mmol of pyrrole and 2 mmol of dopamine hydrochloride to 30 mL of water with pH = 8 and mix evenly, add 3 g of ammonium persulfate to it, stir and react at 4°C for 24 hours, and then centrifugally wash to obtain a polypyrrole-polydopamine nanocomposite Material;
[0045] 2) Place 1mg of polypyrrole-polydopamine nanocomposite in 1mol / L dilute hydrochloric acid containing doxorubicin hydrochloride and graphene oxide aqueous solution for 24 hours, and centrifuge to obtain graphene oxide-polypyrrole-polydopamine nanocomposites. For the composite drug-loading material, the concentration of doxorubicin hydrochloride is 4 mg / mL, the volume of dilute hydrochloric acid is 1 mL, the concentration of graphene oxide is 1 mg / mL, and the volume of graphene oxide solution is 2 mL;
[0046] 3) Mix 1 mg of graphene oxide-polypyrrole-polydopamine...
Embodiment 2
[0049] This embodiment provides a preparation method of a composite drug-loaded gel, which differs from Example 1 in that:
[0050] In step 1), 1 mmol of pyrrole and 2 mmol of dopamine hydrochloride were added to 30 mL of water with pH=9 and mixed uniformly;
[0051] In step 2), 2 mg of polypyrrole-polydopamine nanocomposite material was placed in 1mol / L dilute hydrochloric acid and graphene oxide aqueous solution containing methotrexate in turn for 36 hours, and then centrifugally adsorbed to obtain graphene oxide-polypyrrole-polydopamine Nanocomposite drug-loaded material, the concentration of methotrexate is 0.5mg / mL, the volume of dilute hydrochloric acid is 2mL, the concentration of graphene oxide is 2mg / mL, and the volume of graphene oxide solution is 1mL;
[0052] In step 3), after mixing 2 mg of graphene oxide-polypyrrole-polydopamine nanocomposite drug-loaded material with sodium alginate aqueous solution, add calcium chloride solution, stir and let stand for 36 hours...
PUM
Property | Measurement | Unit |
---|---|---|
concentration | aaaaa | aaaaa |
volume | aaaaa | aaaaa |
volume | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com